SINGLE-CENTER, OPEN-LABEL, PLACEBO-CONTROLLED TRIAL TO DETERMINE THE EFFECTS OF 900 MG OXCARBAZEPINE TWICE-DAILY ON MARKERS OF ENZYME-INDUCTION IN HEALTHY MALE-VOLUNTEERS
Lj. Brookman et al., SINGLE-CENTER, OPEN-LABEL, PLACEBO-CONTROLLED TRIAL TO DETERMINE THE EFFECTS OF 900 MG OXCARBAZEPINE TWICE-DAILY ON MARKERS OF ENZYME-INDUCTION IN HEALTHY MALE-VOLUNTEERS, Epilepsia, 36, 1995, pp. 161-161